Recent news highlights include Leatt’s extension of its share repurchase program to March 31, 2026, a 61% revenue increase in Q2 2025, and continued revenue growth amid market challenges.

• Leatt extended its share repurchase program to March 31, 2026, indicating ongoing capital return initiatives [N1].
• The company reported a 61% jump in Q2 2025 revenue compared to the prior year period, reflecting strong sales growth [N2].
• Leatt showed revenue growth amid challenges in the broader market environment, demonstrating resilience [N3].
• Leatt was featured among notable small-cap growth stocks in 2021, highlighting its market recognition [N4].

Leatt’s exclusive rights to the patented Leatt-Brace® technology and its diversified product portfolio position it well within the growing motor sports and cycling safety markets. The company’s expanding manufacturing footprint beyond China and strong global distribution network support scalability. Recent revenue growth, including a 61% increase in Q2 2025, and profitability improvements demonstrate operational execution. Continued product innovation, strategic marketing, and potential market expansion into adventure and other recreational segments could enhance brand loyalty and sales. The extension of the share repurchase program indicates confidence in capital allocation.

Leatt faces risks from global economic fragility that could reduce consumer demand and disrupt its distributor network. Trade restrictions and tariffs on imports from China may increase costs and complicate supply chains. The company is exposed to product liability litigation risks inherent in safety equipment manufacturing, which could result in costly claims despite insurance coverage. Intellectual property enforcement requires ongoing legal efforts and resources. Foreign currency fluctuations, especially involving the South African Rand, may impact financial results. Natural or man-made catastrophic events and global conflicts could disrupt operations and sales. Competitive pressures and market acceptance of new products remain challenges.

Leatt Corp’s moat is anchored in its exclusive global license to the patented Leatt-Brace® neck protection system, a unique and proprietary technology designed to prevent cervical spine injuries. This intellectual property, combined with extensive international safety certifications and a diversified product portfolio, creates barriers to entry for competitors. The company’s established global distribution network, direct-to-consumer digital channels, and OEM relationships further strengthen its market position. Additionally, Leatt’s commitment to research and development and quality control supports product innovation and brand reputation in the personal protective equipment market.

• Global Economic Fragility: Economic downturns in key markets could reduce demand for Leatt’s products and affect distributor inventory management and receivables collection.
• Trade Restrictions and Tariffs: Tariffs on imports from China and other trade barriers could increase manufacturing costs and disrupt supply chains.
• Product Liability Litigation: Exposure to claims alleging product failure could result in significant financial losses despite insurance coverage.
• Intellectual Property Protection: Maintaining and enforcing patents and trademarks requires ongoing legal action and resources.
• Foreign Currency Fluctuations: Revenue and costs denominated in multiple currencies, including South African Rand, expose the company to exchange rate risks.
• Natural or Man-made Catastrophic Events: Events such as pandemics, natural disasters, or geopolitical conflicts could disrupt manufacturing, distribution, and consumer demand.

• Leatt Corp was incorporated in Nevada in 2005 and acquired exclusive global manufacturing, distribution, sale, and use rights to the patented Leatt-Brace® neck protection system, owned by Xceed Holdings, controlled by the company's founder Dr. Christopher Leatt [S1].
• Leatt designs, develops, markets, and distributes personal protective equipment (PPE) for motor sports and leisure activities including motorcycles, bicycles, snowmobiles, and ATVs [S1].
• The company sells products worldwide through approximately 61 distributors and 6 e-commerce partners, with direct distribution in the U.S. (Two Eleven) and South Africa (Leatt SA) [S1].
• Leatt acts as an original equipment manufacturer (OEM) for PPE sold by other international brands [S1].
• The flagship product is the Leatt-Brace®, a patented injection molded neck protection system designed to prevent cervical spine injuries, with exclusive global rights under license [S1].
• The company also develops and markets helmets, body protection products, goggles, sunglasses, and technical apparel under the Leatt® brand, including specialized ranges for powersports, cycling, adventure, and other recreational markets [S1].
• Leatt’s products comply with multiple international safety standards and certifications including CE, ECE, DOT, CPSC, ASTM, ACU, JIS, ABNT, CCC, and NTA8776 among others, depending on product and market [S1].
• Manufacturing is outsourced primarily to third-party manufacturers in China, with expanding capacity in Thailand, Cambodia, and Bangladesh. Quality control is maintained through on-site inspections by company employees and consultants [S1].
• The company’s research and development is conducted at its Cape Town, South Africa headquarters, employing 4 full-time R&D staff and external consultants [S1].
• Leatt’s revenue is generated from product sales to distributors and retailers globally, with approximately 72% of revenue from international customers as of 2025 [S1].
• The company’s largest customers account for less than 10% of consolidated revenues, indicating diversified customer base [S1].
• Leatt’s financial snapshot for the fiscal year ended December 31, 2025 includes revenue of $61.9 million, net income of $3.26 million, basic EPS of $0.53, cash and equivalents of $12.99 million, current assets of $47.6 million, current liabilities of $9.78 million, with a current ratio of 4.87 and cash ratio of 1.33 [S1].
• The company pays licensing fees to Xceed Holdings of 4% of neck brace sales revenue and 1% royalty fees to a trust controlled by a former director, based on quarterly sales [S1].
• Recent quarterly results show revenue growth with Q2 2025 revenue increasing 61% year-over-year, and net income improvements in 2025 compared to 2024 [N2][S2].
• Leatt extended its share repurchase program to March 31, 2026, indicating capital return activity [N1].
• The company faces risks including global economic fragility, trade restrictions (notably tariffs on China imports), fuel price fluctuations affecting shipping costs, product liability litigation exposure, intellectual property protection challenges, foreign currency fluctuations, and potential disruptions from natural or man-made catastrophic events [S1][S2].